ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,003Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 783

$843K Total Retail Price of All Prescriptions

Rank: 81 out of 783

599 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 599 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

25% of this provider’s 599 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 13,540 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 891 530 S3 1 2
PRAVASTATIN SODIUM 888 707 2 14
LEVOTHYROXINE SODIUM 650 546 3 1
AMLODIPINE BESYLATE 585 486 4 5
OMEPRAZOLE 584 424 5 6
LISINOPRIL 511 325 6 4
FUROSEMIDE 510 394 7 7
METFORMIN HCL 431 309 8 8
ATORVASTATIN CALCIUM 361 248 9 11
GABAPENTIN 349 204 10 15
POTASSIUM CHLORIDE 342 265 11 16
ATENOLOL 337 283 12 17
METOPROLOL TARTRATE 313 251 13 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 285 231 14 33
HYDROCHLOROTHIAZIDE 257 220 15 12
LOSARTAN POTASSIUM 237 214 16 18
TRIAMTERENE-HCTZ 221 169 17 42
DOXAZOSIN MESYLATE 218 171 18 87
METOPROLOL SUCCINATE 214 160 19 13
CITALOPRAM HBR 203 150 20 19
GLIMEPIRIDE 190 115 21 34
ZOLPIDEM TARTRATE 185 97 22 23
WARFARIN SODIUM 179 127 23 10
SIMVASTATIN 174 162 24 3
CLOPIDOGREL 171 142 25 29
LOSARTAN-HYDROCHLOROTHIAZIDE 165 153 26 53
NEXIUM 163 79 27 28
CARVEDILOL 162 131 28 21
SPIRONOLACTONE 160 99 29 57
FLUOXETINE HCL 149 101 30 45
CYMBALTA 145 59 31 35
ALENDRONATE SODIUM 144 126 32 25
TRAMADOL HCL 144 87 32 20
LOVASTATIN 143 139 34 58
KLOR-CON M20 139 109 35 48
FLUTICASONE PROPIONATE 138 107 36 46
TRAZODONE HCL 137 70 37 39
SERTRALINE HCL 130 113 38 22
ALLOPURINOL 127 127 39 31
MIRTAZAPINE 125 83 40 52
AZITHROMYCIN 122 72 41 41
JANUVIA 115 111 42 73
ENALAPRIL MALEATE 115 95 42 68
PLAVIX 114 89 44 51
AMITRIPTYLINE HCL 114 60 R 44 77
LANTUS 112 76 46 38
FAMOTIDINE 111 79 47 55
FENOFIBRATE 111 51 47 66
CRESTOR 109 62 49 27
ESCITALOPRAM OXALATE 107 28 50 54
PROAIR HFA 106 45 51 56
ISOSORBIDE MONONITRATE ER 105 99 52 40
MELOXICAM 105 79 52 37
DIGOXIN 103 68 54 61
TAMSULOSIN HCL 101 94 55 26
OXYBUTYNIN CHLORIDE ER 96 94 56 117
HYDRALAZINE HCL 87 78 57 78
ROPINIROLE HCL 87 54 57 74
ALPRAZOLAM 86 59 59 145
COMBIVENT 86 44 59 120
GLIPIZIDE 85 82 61 71
PAROXETINE HCL 85 59 61 69
CYCLOBENZAPRINE HCL 77 31 R 63 63
PANTOPRAZOLE SODIUM 75 32 64 30
KLOR-CON 10 73 51 65 102
EVISTA 71 71 66 92
GLIPIZIDE ER 69 69 67 84
ATENOLOL-CHLORTHALIDONE 67 64 68 213
PREDNISONE 67 61 68 36
ADVAIR DISKUS 66 40 70 50
CIPROFLOXACIN HCL 65 48 71 62
PROPRANOLOL HCL 65 45 71 129
VERAPAMIL ER 64 49 73 119
DILTIAZEM 24HR ER 61 49 74 122
GEMFIBROZIL 60 57 75 105
QUINAPRIL HCL 60 49 75 195
LANTUS SOLOSTAR 57 36 77 91
LIPITOR 54 23 78 114
FENTANYL 54 30 S2 78 65
LYRICA 54 34 78 98
ESTRADIOL 52 28 R 81 204
VENLAFAXINE HCL ER 51 38 82 100
HUMULIN 70-30 51 48 82 211
ACTOS 50 32 84 149
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 23, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.